2014
DOI: 10.2341/13-131-lr
|View full text |Cite
|
Sign up to set email alerts
|

In Vitro Evaluation of Benzalkonium Chloride in the Preservation of Adhesive Interfaces

Abstract: Benzalkonium chloride preserves resin-dentin bonds by reducing collagen solubilization. When incorporated into adhesive blends, benzalkonium chloride provides comparable bond stability to other inhibitors and application protocols without adding more steps to the bonding sequence. SUMMARYInhibition of endogenous dentin matrix metalloproteinases (MMPs) by benzalkonium chloride (BAC) decreases collagen solubilization and may help improve resin-dentin bond stability. Objective: This study evaluated the resin-dent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
31
3
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(37 citation statements)
references
References 20 publications
1
31
3
1
Order By: Relevance
“…No differences in mass loss or HYP release were found when the beams were pretreated with 0.5% or 1.0% BAC, but both demonstrated less mass loss and HYP release than the control beams. These findings confirm those from our previous study and from other studies, which have also reported BAC to be an effective inhibitor of MMP activity .…”
Section: Discussionsupporting
confidence: 93%
“…No differences in mass loss or HYP release were found when the beams were pretreated with 0.5% or 1.0% BAC, but both demonstrated less mass loss and HYP release than the control beams. These findings confirm those from our previous study and from other studies, which have also reported BAC to be an effective inhibitor of MMP activity .…”
Section: Discussionsupporting
confidence: 93%
“…Commercially available BAC-containing etchants can be used without affecting immediate bond strength to enamel or dentin. 96 BAC also inhibits dentinal MMPs [97][98][99] and may also improve the durability of dentin bonding when incorporated either into the etchant or the adhesive. 99 Tetracyclines and their antimicrobially inactive analogs inhibit MMP with their cationic chelating properties and have been shown to inhibit salivary and dentinal MMPs as well.…”
Section: Enzyme Inhibitorsmentioning
confidence: 99%
“…74,118,119 In this sense, a growing predisposition among clinicians in properly applying 0.2-2% CHX for 15-60 s for re-wetting the collagen network on acid-etched dentin 77,79,89,120 to minimize degradation of resin-dentin bonds, can be currently appreciated. 115,119 Tough medium-term randomized clinical trials (18-36 months) does not show significant beneficial results from incorporating CHX to adhesive treatment of dentin. 121,122,123 Loguercio et al, 105 incite researchers to evaluate the only one proven clinically and easy to adopt strategy 88 after long-term follow-ups, when the benefits of CHX would possibly turn out to be detectable.…”
Section: Enzymatic Inhibitorsmentioning
confidence: 99%
“…106 After oversaturating proteases binding sites, if still available (higher concentrations), it can remain bound to collagen fibrils for later release. 115 Adversely, a limitation of CHX indication as an enzymatic inhibitor is that its effect seems not to be indefinitely long. 85 Because CHX molecule is large and water soluble, it may be gradually leached out from the adhesive interface, 92 especially when in contact with an external environment (through marginal gaps, for instance).…”
Section: Enzymatic Inhibitorsmentioning
confidence: 99%